Literature DB >> 6421759

Blood group distribution in women with ovarian cancer.

E Björkholm.   

Abstract

The distribution of ABO blood groups and Rh factor was studied in 1930 patients treated at Radiumhemmet for ovarian tumour in the period 1958-1973. The tumour was malignant in 1732 cases and of borderline malignancy in 198. A predominance of blood group A at the expense of group O emerged when the series was compared with findings in 24 120 healthy conscripts. In the present series, the disparity between the frequencies of blood groups A and O appeared to increase the risk of ovarian carcinoma by 19%. The frequencies of blood groups among various histological subgroups are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421759     DOI: 10.1093/ije/13.1.15

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

1.  A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China.

Authors:  Miao-Zhen Qiu; Dong-Sheng Zhang; Dan-Yun Ruan; Hui-Yan Luo; Zhi-Qiang Wang; Zhi-Wei Zhou; Feng-Hua Wang; Yu-Hong Li; Rui-Hua Xu
Journal:  Med Oncol       Date:  2010-11-04       Impact factor: 3.064

2.  ABO blood group and incidence of epithelial ovarian cancer.

Authors:  Margaret A Gates; Brian M Wolpin; Daniel W Cramer; Susan E Hankinson; Shelley S Tworoger
Journal:  Int J Cancer       Date:  2010-03-22       Impact factor: 7.396

3.  Ovarian cancer and ABO blood groups.

Authors:  J Henderson; V Seagroatt; M Goldacre
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

4.  ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.

Authors:  Elizabeth M Poole; Margaret A Gates; Brigit A High; Stephen J Chanock; Daniel W Cramer; Julie M Cunningham; Brooke L Fridley; Simon A Gayther; Ellen L Goode; Edwin S Iversen; Jolanta Lissowska; Rachel T Palmieri Weber; Paul D P Pharoah; Catherine M Phelan; Susan J Ramus; Joellen M Schildkraut; Rebecca Sutphen; Ya-Yu Tsai; Jonathan Tyrer; Robert A Vierkant; Nicolas Wentzensen; Hannah P Yang; Kathryn L Terry; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2012-09-08       Impact factor: 2.506

5.  Blood type, ABO genetic variants, and ovarian cancer survival.

Authors:  Gabriella D Cozzi; Rebecca T Levinson; Hilary Toole; Malcolm-Robert Snyder; Angie Deng; Marta A Crispens; Dineo Khabele; Alicia Beeghly-Fadiel
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

6.  Assessment of gynecological and lifestyle-related risk factors of ovarian cancer.

Authors:  Gazala Abdulaziz; Natalia Anna Welc; Emilia Gąsiorowska; Ewa Nowak-Markwitz
Journal:  Prz Menopauzalny       Date:  2021-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.